OA07356A - Substituted 3,4-Diamino-1,2,5-thiadiazoles possessing histamine H2 receptor antagonist activity. - Google Patents

Substituted 3,4-Diamino-1,2,5-thiadiazoles possessing histamine H2 receptor antagonist activity.

Info

Publication number
OA07356A
OA07356A OA57955A OA57955A OA07356A OA 07356 A OA07356 A OA 07356A OA 57955 A OA57955 A OA 57955A OA 57955 A OA57955 A OA 57955A OA 07356 A OA07356 A OA 07356A
Authority
OA
OAPI
Prior art keywords
thiadiazoles
histamine
diamino
possessing
substituted
Prior art date
Application number
OA57955A
Other languages
French (fr)
Inventor
Ronnie Ray Crenshaw
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of OA07356A publication Critical patent/OA07356A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
OA57955A 1982-03-29 1983-03-29 Substituted 3,4-Diamino-1,2,5-thiadiazoles possessing histamine H2 receptor antagonist activity. OA07356A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29

Publications (1)

Publication Number Publication Date
OA07356A true OA07356A (en) 1984-08-31

Family

ID=23429274

Family Applications (1)

Application Number Title Priority Date Filing Date
OA57955A OA07356A (en) 1982-03-29 1983-03-29 Substituted 3,4-Diamino-1,2,5-thiadiazoles possessing histamine H2 receptor antagonist activity.

Country Status (30)

Country Link
JP (2) JPS58180477A (en)
KR (1) KR880002209B1 (en)
AT (1) AT386599B (en)
AU (2) AU557577B2 (en)
BE (1) BE896291A (en)
CH (2) CH660880A5 (en)
CS (2) CS250229B2 (en)
DD (2) DD219768A5 (en)
DE (1) DE3311281A1 (en)
DK (2) DK166677B1 (en)
ES (3) ES8404683A1 (en)
FR (2) FR2542741B1 (en)
GB (2) GB2117769B (en)
GR (1) GR78524B (en)
HU (2) HU196386B (en)
IE (1) IE55596B1 (en)
IL (1) IL68259A0 (en)
IT (1) IT1164633B (en)
LU (1) LU84716A1 (en)
MY (1) MY8700942A (en)
NL (1) NL8301063A (en)
NO (1) NO163055C (en)
NZ (1) NZ203726A (en)
OA (1) OA07356A (en)
PT (1) PT76459B (en)
SE (2) SE461040B (en)
SU (2) SU1419518A3 (en)
YU (1) YU44849B (en)
ZA (1) ZA832154B (en)
ZW (1) ZW7683A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (en) * 1986-06-30 1994-03-30 フアナツク株式会社 Direct pressure type mold clamping mechanism
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
FI76795C (en) * 1979-09-04 1988-12-12 Bristol Myers Co Process for the preparation of novel, therapeutically useful 3,4-disubstituted 1,2,5-thiadiazole-1-oxides and -1,1-dioxides and novel intermediates
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
NO163055C (en) 1990-03-28
CH655111A5 (en) 1986-03-27
DE3311281A1 (en) 1983-11-24
HU188742B (en) 1986-05-28
AU557577B2 (en) 1986-12-24
NO163055B (en) 1989-12-18
ZA832154B (en) 1983-12-28
SE8704689D0 (en) 1987-11-25
ZW7683A1 (en) 1984-01-04
JPH0568472B2 (en) 1993-09-29
DK81192A (en) 1992-06-18
DK81192D0 (en) 1992-06-18
IE55596B1 (en) 1990-11-21
DD210909A5 (en) 1984-06-27
ES527685A0 (en) 1985-06-16
YU74483A (en) 1986-02-28
JPS58180477A (en) 1983-10-21
SE8301725L (en) 1983-11-25
KR880002209B1 (en) 1988-10-18
LU84716A1 (en) 1983-12-05
GB8308518D0 (en) 1983-05-05
DD219768A5 (en) 1985-03-13
HU196386B (en) 1988-11-28
BE896291A (en) 1983-09-28
SE8704689L (en) 1987-11-25
NZ203726A (en) 1986-05-09
GR78524B (en) 1984-09-27
FR2597867A1 (en) 1987-10-30
ATA111083A (en) 1988-02-15
NO831100L (en) 1983-09-30
YU44849B (en) 1991-04-30
FR2542741A1 (en) 1984-09-21
JPH06135925A (en) 1994-05-17
ES520982A0 (en) 1984-05-16
GB2117769A (en) 1983-10-19
KR840004095A (en) 1984-10-06
SU1419518A3 (en) 1988-08-23
FR2542741B1 (en) 1989-12-08
AU6327286A (en) 1987-01-08
DK141383D0 (en) 1983-03-28
IT8348005A0 (en) 1983-03-28
PT76459B (en) 1986-03-11
IE830686L (en) 1983-09-29
SE8301725D0 (en) 1983-03-28
SE464302B (en) 1991-04-08
CS250240B2 (en) 1987-04-16
IL68259A0 (en) 1983-06-15
GB2117769B (en) 1985-08-29
DK141383A (en) 1983-09-30
CH660880A5 (en) 1987-05-29
MY8700942A (en) 1987-12-31
AU1290783A (en) 1983-10-06
GB2149406B (en) 1986-01-02
CS250229B2 (en) 1987-04-16
ES8505978A1 (en) 1985-06-16
GB8432809D0 (en) 1985-02-06
SE461040B (en) 1989-12-18
FR2597867B1 (en) 1989-12-08
IT1164633B (en) 1987-04-15
SU1355123A3 (en) 1987-11-23
AU586037B2 (en) 1989-06-29
ES8404683A1 (en) 1984-05-16
GB2149406A (en) 1985-06-12
NL8301063A (en) 1983-10-17
AT386599B (en) 1988-09-12
PT76459A (en) 1983-04-01
ES527686A0 (en) 1985-06-16
ES8505977A1 (en) 1985-06-16
DK166677B1 (en) 1993-06-28

Similar Documents

Publication Publication Date Title
ATE30023T1 (en) LEUKOTRIAN ANTAGONISTS.
FI922143A7 (en) MUSCARIN RECEPTOR ANTAGONIST.
FI834739A7 (en) Articulated seat.
FI922344L (en) MUSCARIN RECEPTOR ANTAGONIST.
FI840154A7 (en) VIDHAEFTNINGSHINDRANDE, LOESNINGSMEDELSFRI SILICON KOMPOSITION.
DE3574665D1 (en) GLUTAMATE RECEPTOR INHIBITANT.
FI854957A0 (en) BENTONIT INNEHAOLLANDE, MJUKGOERANDE, FLYTANDE TVAETTMEDEL FOER TEXTILER.
OA07356A (en) Substituted 3,4-Diamino-1,2,5-thiadiazoles possessing histamine H2 receptor antagonist activity.
ZA783141B (en) Histamine h2 receptor antagonists
DE3578233D1 (en) PHOTO RECEPTOR.
FI845095A7 (en) Aminoimidazolone derivatives as histamine H2 antagonists.
OA08039A (en) Substituted 3,4-diamido-1,2,5-thiadiazoles exhibiting histamine H2 receptor antagonist activity.
FI861715L (en) MONOCLONAL ANTIUROKINASE-ANTIKROPP, DEN INNEHAOLLANDE MATRIS OCH BIOKEMISKA TESTPACKNINGAR, I VILKA DEN ANVAENDES.
IT8321317A0 (en) VEHICLE SEAT, FOR AT LEAST TWO PEOPLE.
NO843726L (en) 2,5-DISUBSTITUTED-4 (3H) -PYRIMIDONES WITH HISTAMINE H2 RECEPTOR ANTAGONIST EFFECT
FI922346A7 (en) MUSCARIN RECEPTOR ANTAGONIST.
IT8125288A0 (en) LOCKING DEVICE, ESPECIALLY FOR BUILT-IN BAGS.
ES515054A0 (en) "PROCEDURE FOR THE PREPARATION OF 2-AMINO-5-MERCAPTO-1,3,4-TIADIAZOLES".
IT8320738A0 (en) PROCEDURE FOR PRODUCING 2,3-DIHYDRO-2,2-DIMETHYL-7-BENZOPURANOL.
ES265348Y (en) "HEAD-TERMINAL, FOR TUBULAR ELEMENTS OF METALLIC STRUCTURES".
IE810940L (en) 17-substituted-6-desoxy-7,8-dihydro-6ó-methylnoroxymorphone¹narcotic antagonists
IT1209497B (en) PROCEDURE FOR PREVENTING PHOTOTOXIC REACTIONS.
ATE19775T1 (en) AMINOPYRIMIDINONE DERIVATIVES USABLE AS HISTAMINE H1 ANTAGONISTS.
TR21881A (en) SOME 2. (2-SUBSTITUTED BENZOIL) -1,3-SIKLOHEKSANADIONS
ES264760Y (en) "BALIZATION MILESTONE".